TOP 100 MEDICAL SITES
| |||
|
| |||
| |||
|
| |||
| Earnings Preview: Celgene Corp. theflyonthewall.com submits: Celgene Corp. (CELG) is expected to report Q1 earnings on Thursday, April 29 before the market open, with a conference call scheduled for 9 am ET. GuidanceAnalysts are looking for EPS of 60c on revenue of $758.36M. The consensus range is 54c-65c for EPS, and $728.50M-$777.90M for revenue according to First Call. Possible positives for Celgene's Q1 may come from Revlimid and Vidaza sales. The company is expanding its Revlimid presence globally and in its Q4 release the company reported global Revlimid net product sales increased 35% to $497M and global Vidaza sales increased 68% to $117M. Celgene anticipates Revlimid net product sales to increase approximately 25% to a range of $2.1B-$2.2B. Complete Story » seekingalpha.com |
ITPvillage.com, a new community for ITP patients - Video First Dedicated Virtual Community for Immune Thrombocytopenia (ITP) Patients Launched Today feedproxy.google.com |
Sales Boost Novartis Results Novartis reported a sharp rise in second-quarter net profit on healthy drug sales and cost cuts, prompting the Swiss drug giant to lift its full-year sales guidance. online.wsj.com |
New Clue in Heart Disease Researchers have discovered a mysterious protein in cells of people as they age and are examining its role in heart disease. online.wsj.com |
For Older Athletes, Getting Fit Without the Pain Athletes over 50 usually hire a physical therapist after a problem, often an injury if not surgery. But more older people are starting to hire physical therapists before they get hurt to fill the role of personal trainer. online.wsj.com |